News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
56,653 Results
Type
Article (3609)
Company Profile (13)
Press Release (53031)
Section
Business (21436)
Career Advice (66)
Deals (3769)
Drug Delivery (10)
Drug Development (4111)
Employer Resources (12)
FDA (826)
Job Trends (1056)
News (29095)
Policy (1307)
Tag
2024 BioCapital Digital (1)
2024 Biotech Bay Standard (3)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (1)
Academia (237)
Allergies (3)
Alliances (5157)
ALS (4)
Alzheimer's disease (119)
Antibody-drug conjugate (ADC) (6)
Approvals (826)
Artificial intelligence (38)
Autoimmune disease (1)
Bankruptcy (32)
Best Places to Work (750)
BIOSECURE Act (2)
Biosimilars (7)
Biotechnology (13)
Bladder cancer (4)
Brain cancer (1)
Breast cancer (12)
Cancer (113)
Cardiovascular disease (8)
Career advice (59)
Career pathing (3)
CAR-T (13)
Cell therapy (31)
Clinical research (3133)
Collaboration (75)
Compensation (2)
Complete response letters (1)
COVID-19 (157)
CRISPR (3)
C-suite (36)
Cystic fibrosis (14)
Data (112)
Denatured (2)
Depression (4)
Diabetes (13)
Diagnostics (572)
Digital health (3)
Diversity (1)
Diversity, equity & inclusion (2)
Drug discovery (16)
Drug pricing (11)
Duchenne muscular dystrophy (3)
Earnings (4289)
Editorial (4)
Employer resources (10)
Events (5203)
Executive appointments (106)
FDA (886)
Featured Employer (2)
Friedreich's ataxia (1)
Funding (339)
Gene editing (9)
Generative AI (3)
Gene therapy (25)
GLP-1 (64)
Government (124)
Guidances (4)
Healthcare (1256)
Huntington's disease (1)
IgA nephropathy (3)
Immunology and inflammation (13)
Indications (1)
Infectious disease (165)
Inflammatory bowel disease (12)
Inflation Reduction Act (4)
Influenza (1)
Intellectual property (9)
Interviews (5)
IPO (1764)
IRA (8)
Job creations (316)
Job search strategy (57)
Labor market (5)
Layoffs (32)
Leadership (1)
Legal (273)
Liver cancer (3)
Lung cancer (15)
Lymphoma (5)
Machine learning (1)
Management (4)
Manufacturing (25)
MASH (9)
Medical device (1272)
Medtech (1274)
Mergers & acquisitions (2062)
Metabolic disorders (58)
Multiple sclerosis (2)
NASH (2)
Neurodegenerative disease (10)
Neuropsychiatric disorders (1)
Neuroscience (150)
NextGen: Class of 2025 (962)
Non-profit (289)
Northern California (209)
Now hiring (1)
Obesity (36)
Opinion (47)
Ovarian cancer (3)
Pain (7)
Pancreatic cancer (1)
Parkinson's disease (8)
Partnered (3)
Patents (8)
Patient recruitment (8)
Peanut (3)
People (8728)
Pharmaceutical (4)
Phase I (1063)
Phase II (1448)
Phase III (884)
Pipeline (55)
Podcasts (5)
Policy (13)
Postmarket research (95)
Preclinical (581)
Press Release (6)
Prostate cancer (6)
Psychedelics (2)
Radiopharmaceuticals (25)
Rare diseases (31)
Real estate (575)
Recruiting (5)
Regulatory (987)
Reports (3)
Research institute (166)
Resumes & cover letters (9)
Schizophrenia (3)
Series A (94)
Series B (66)
Service/supplier (1)
Sickle cell disease (1)
Southern California (149)
Special edition (2)
Spinal muscular atrophy (1)
Sponsored (1)
Startups (2175)
Supply chain (4)
The Weekly (3)
United States (1357)
Vaccines (25)
Venture capitalists (35)
Webinars (4)
Weight loss (19)
Women's health (2)
Date
Last 7 days (45)
Last 30 days (198)
Last 365 days (2765)
2025 (653)
2024 (2934)
2023 (3113)
2022 (5523)
2021 (4858)
2020 (4673)
2019 (4313)
2018 (3461)
2017 (3047)
2016 (2526)
2015 (2923)
2014 (2099)
2013 (1739)
2012 (1852)
2011 (2067)
2010 (2170)
Location
Africa (63)
Alabama (5)
Alaska (2)
Arizona (10)
Arkansas (5)
Asia (3986)
Australia (479)
California (454)
Canada (413)
China (38)
Colorado (13)
Connecticut (24)
Delaware (5)
Europe (8255)
Florida (29)
Georgia (14)
Idaho (5)
Illinois (40)
India (5)
Indiana (18)
Iowa (1)
Japan (20)
Kansas (7)
Kentucky (1)
Louisiana (4)
Maine (6)
Maryland (41)
Massachusetts (273)
Michigan (8)
Minnesota (13)
Missouri (9)
Nevada (1)
New Hampshire (5)
New Jersey (67)
New Mexico (4)
New York (101)
North Carolina (55)
Northern California (209)
Ohio (22)
Oklahoma (3)
Oregon (2)
Pennsylvania (44)
Puerto Rico (3)
South America (98)
South Carolina (1)
Southern California (149)
Tennessee (6)
Texas (56)
Utah (14)
Virginia (8)
Washington D.C. (1)
Washington State (28)
Wisconsin (6)
56,653 Results for "sofinnova ventures".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Forth Tx Launches With Backing From Sofinnova Partners to Revolutionize Fibrosis Treatments
March 18, 2025
·
3 min read
Press Releases
Sofinnova Partners and Gustave Roussy launch first biotech company through Strategic Partnership
March 18, 2025
·
4 min read
Press Releases
BioClec Launches With Backing From Sofinnova Partners to Pioneer Breakthrough Alzheimer’s Therapies
March 18, 2025
·
2 min read
Press Releases
Sofinnova Partners Exceeds Target With €165M Biotech Acceleration Fund, Europe’s Largest, With Strong Pharma Support
March 18, 2025
·
3 min read
Press Releases
Sofinnova Partners Raises €1.2 Billion to Fuel the Next Wave of Life Sciences Innovation
March 4, 2025
·
3 min read
Sofinnova Partners Brings in Dr. Joshua Makower, Stanford Biodesign Co-Founder, as Venture Partner
Sofinnova Partners announced that Dr. Joshua Makower, co-founder and director of the Stanford Byers Center for Biodesign, has joined Sofinnova as an advisory Venture Partner.
January 4, 2024
·
3 min read
Deals
Sofinnova Partners Portfolio Company Amolyt Pharma to be Acquired by AstraZeneca
Sofinnova Partners announced that its portfolio company, Amolyt Pharma, a global, clinical-stage biopharmaceutical company specializing in the development of therapeutic peptides for rare endocrine and related diseases has entered into a definitive agreement with AstraZeneca for its acquisition, with an upfront purchase price of $800 million and a potential milestone payment of $250 million.
March 14, 2024
·
5 min read
Business
Sofinnova Partners Enhances Leadership in Medtech Acceleration with Key Appointments
Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London, and Milan, announced the strategic strengthening of its medtech acceleration team with the appointment of Mano Iyer as Partner and the promotion of Cécile Dupont to Partner.
November 13, 2023
·
3 min read
Sofinnova Partners Launches Biovelocita, the First Pan-European Investment Strategy Dedicated to the Creation and Acceleration of Biotech Startups
Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London, and Milan, announced the launch of Biovelocita, an investment strategy dedicated entirely to the creation and acceleration of biotech startups in Europe.
December 13, 2023
·
4 min read
Business
Sofinnova Partners and Gustave Roussy forge strategic alliance to boost oncology startup acceleration in France
Sofinnova Partners and Gustave Roussy announced the launch of a strategic collaboration as part of Sofinnova Biovelocita, the first pan-European investment strategy dedicated to the creation and acceleration of biotech startups.
December 13, 2023
·
5 min read
1 of 5,666
Next